Transgender People: Provision of Healthcare

Emily Darlington Excerpts

Tuesday 16th December 2025 Westminster Hall

[Rachel Taylor (North Warwickshire and Bedworth) (Lab)]

I beg to move,

That this House has considered the provision of healthcare for transgender people.

It is a pleasure to serve under your chairmanship, Mr Turner. This debate is about healthcare for trans adults. I know that a lot has been said in this House in recent weeks about care for young people questioning their gender identity, and particularly about the recent announcement of a trial of puberty blockers. I do not wish to repeat that debate here, other than to say that I welcome the fact that the trial is going ahead to ensure we can get the evidence that we need.

I want to begin with the experience of one of my constituents, because this debate must be about real people, not headlines in The Times or the Daily Mail, not culture war soundbites, not the opinions of Donald Trump or J. K. Rowling, and certainly not whatever bile is being pushed out by transphobic trolls on social media. This is about real people’s lives.

Earlier this year, my constituent, a trans woman, came to my surgery to share her experience of accessing healthcare locally. At her GP practice, she was told that she could not use the women’s toilets and must use the men’s instead, and she was repeatedly misgendered by staff. She faced difficulties simply getting her preferred name recorded correctly. On one occasion she was even told that she could not wait in the waiting room because she “scared other patients.”

My constituent is also struggling to access the gender-affirming care that she needs. There are no adult gender services in Birmingham, let alone in my constituency of North Warwickshire and Bedworth, meaning that she would have to travel to Nottingham for treatment. She is stuck on a waiting list with no idea when she will finally receive care. Because she cannot get NHS support, she is taking hormone replacement therapy on a private prescription and is understandably anxious about dosage and the lack of monitoring or regulation. She is not alone.

[Emily Darlington (Milton Keynes Central) (Lab)]

My hon. Friend is making a powerful speech and bringing the debate back to people, which is where it needs to be. I want to highlight a case in my constituency of a young transgender person who spent two years on the under-18s waiting list for an initial appointment. They have now aged out of that waiting list and potentially have a six-year wait, meaning that when they are able to speak to a doctor or a health professional it will have been eight years. Their parents approached me to tell me how much that is damaging their young one.

[Karl Turner (in the Chair)]

Order. I remind Members that interventions need to be very short. Lots of Members want to take part in this debate and long interventions eat into the time for speeches.